| Patient | Elvis Presley |
|---|---|
| Date of birth | 1935-01-08 |
| Identifiers | MRN HR-ML003-SYN-TD; SSN (made up) 000-03-4417 |
| Document date | 1974-07-10 |
| Author | Coleman Ashby-Nakagawa, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Long-term prescription opioids and benzodiazepines from five prescribers, with fatigue, weight gain, constipation, daytime sleepiness and high blood pressure, in a 39-year-old touring singer who wants to change how he takes his medicines. Please assess for substance use disorders and advise on medication for opioid use disorder and a safe benzodiazepine plan. [S]
Urgency: Within one week, on the day of his one-week primary care review, at his request before a Las Vegas engagement in five weeks. [S]
Questions for the consultant:
Opioids for about five years for back and neck pain from performing, and sedatives for sleep after shows. A hospital stay some years ago in which he was withdrawn from opioids. The monitoring program shows five prescribers and three pharmacies in the past year: hydromorphone 4 mg about five a day and oxycodone 10 mg with acetaminophen about three a day (about 145 MME), diazepam 10 mg three times daily, alprazolam 1 mg up to three a day, and phentermine 37.5 mg each morning (stopped today because of hypertension and glaucoma), with a nonprescription diphenhydramine sleep aid (also stopped). He takes more than prescribed, has tried to cut down, and has cravings; he has never injected and uses no illicit drugs or alcohol (AUDIT-C 0; DAST-10 7). PHQ-9 8 and GAD-7 9, item 9 scored 0; no suicidal thoughts; structured safety assessment done, firearms to be locked. Blood pressure 154/98, pulse 94; BMI 32.5; ALT 72, AST 52, GGT 78; hemoglobin A1c 5.8%; ECG normal, QTc 436 ms. STOP-Bang 6, Epworth 14; in-laboratory polysomnography booked. Glaucoma on latanoprost. Today: naloxone, a single-prescriber agreement, seven-day supplies of his current opioids and benzodiazepines at the verified doses, a locked box and take-back; he preferred to discuss buprenorphine with the specialist before starting [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
10 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydromorphone 4 mg oral tablet, prescribed elsewhere as one tablet every four to six hours as needed for back and neck pain; taking about five a day (20 mg, 100 MME); continued by this clinic only, at the verified dose and seven days at a time, until the addiction medicine consultation | Up to five tablets a day; seven-day supply | Oral route | 1974-07-10 to 1974-07-17 | completed | S |
| Oxycodone 10 mg and acetaminophen 325 mg oral tablet, prescribed by a second prescriber; taking about three a day (45 MME); continued by this clinic only, seven days at a time, until the consultation | Up to three tablets a day; seven-day supply | Oral route | 1974-07-10 to 1974-07-17 | completed | S |
| Diazepam 10 mg oral tablet, one tablet three times daily, prescribed elsewhere for anxiety; continued by this clinic only, seven days at a time | One tablet three times daily; seven-day supply | Oral route | 1974-07-10 to 1974-07-17 | completed | S |
| Alprazolam 1 mg oral tablet, up to three a day as needed, prescribed by a fourth prescriber while on tour; continued by this clinic only, at the verified dose, seven days at a time | Up to three tablets a day; seven-day supply | Oral route | 1974-07-10 to 1974-07-17 | completed | S |
| Phentermine 37.5 mg oral tablet each morning, prescribed by a weight clinic; stopped today because of high blood pressure and his glaucoma | Stopped | Oral route | 1974-07-10 to 1974-07-10 | completed | S |
| Latanoprost 0.005% eye drops, one drop in each eye at bedtime, prescribed by his ophthalmologist | One drop in each eye at bedtime | Ophthalmic route | 1974-07-10 | active | S |
| Naloxone 4 mg nasal spray, one spray into one nostril for a suspected overdose, repeated in the other nostril after two to three minutes if needed; two-pack, with a second for the tour bag | One spray for a suspected overdose; call 911 | Nasal route | 1974-07-10 | active | S |
| Polyethylene glycol 3350, 17 g powder in a glass of water once daily | 17 g in water once daily | Oral route | 1974-07-10 | active | S |
| Senna 8.6 mg oral tablet, two tablets at bedtime | Two tablets at bedtime | Oral route | 1974-07-10 to 1974-08-07 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Fatigue, weight gain of about 14 kg in two years, constipation with a bowel movement every five to seven days, loud snoring with daytime sleepiness, and high blood pressure readings, in a man taking two opioids, two benzodiazepines and an appetite suppressant from five prescribers; under evaluation with addiction medicine, a sleep study and home blood pressure readings | active | confirmed | R53.83 | S — Synthetic presenting problem anchored to the documented prescribed drugs and weight gain; superseded when the consultation and tests made the diagnoses. |
| Obesity, class 1 (BMI 32.5), with prediabetes (hemoglobin A1c 5.8%); recorded without stigma; weight gain began with long touring schedules, night eating after shows and an appetite suppressant that stopped working | active | confirmed | E66.811 | S — Synthetic modern diagnosis anchored to his documented weight gain. |
| Glaucoma secondary to steroids, both eyes, mild stage, after an acute angle-closure episode treated years ago; intraocular pressure controlled on latanoprost under his ophthalmologist; anticholinergic and sympathomimetic drugs to be avoided | active | confirmed | H40.63X1 | S — Synthetic modern diagnosis anchored to his documented glaucoma and the retrospective interpretation of it as steroid-induced; not a claim about his real eyes. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1971 | Glaucoma, with an acute angle-closure episode treated years earlier; under an ophthalmologist's care since | D (CLM-0007) |
| October 15, 1973 | Hospital stay of about two weeks in which, by later testimony, he was withdrawn from narcotic drugs; recorded without detail | D (CLM-0003) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1974-07-10 | Body height | 183 | cm | S |
| 1974-07-10 | Body weight | 109 | kg | S |
| 1974-07-10 | Body mass index (BMI) [Ratio] | 32.5 | kg/m2 | S |
| 1974-07-10 | Systolic blood pressure | 154 | mm[Hg] | S |
| 1974-07-10 | Diastolic blood pressure | 98 | mm[Hg] | S |
| 1974-07-10 | Heart rate | 94 | /min | S |
| 1974-07-10 | Respiratory rate | 16 | /min | S |
| 1974-07-10 | Body temperature | 36.8 | Cel | S |
| 1974-07-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1974-07-10 | Hemoglobin [Mass/volume] in Blood | 15.1 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 1974-07-10 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1974-07-10 | Potassium [Moles/volume] in Serum or Plasma | 4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1974-07-10 | Creatinine [Mass/volume] in Serum or Plasma | 1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1974-07-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1969)/1.73 sq M | 98 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1974-07-10 | Glucose [Mass/volume] in Serum or Plasma | 104 | mg/dL | 70-99 mg/dL | High | S |
| 1974-07-10 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.8 | % | <=5.6% | High | S |
| 1974-07-10 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 72 | U/L | 7-55 U/L | High | S |
| 1974-07-10 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 52 | U/L | 8-48 U/L | High | S |
| 1974-07-10 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 78 | U/L | 8-61 U/L | High | S |
| 1974-07-10 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 1974-07-10 | Albumin/Creatinine [Mass Ratio] in Urine | 14 | mg/g{creat} | <=29 mg/g{creat} | Normal | S |
| 1974-07-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 1974-07-10 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | S | ||
| 1974-07-10 | Total score [DAST-10] | 7 | {score} | S | ||
| 1974-07-10 | Total score [AUDIT-C] | 0 | {score} | S |